Collins (India) Pharmaceuticals Honored as ‘Most Valuable Partner Award’ at "Influx Connect" Business Excellence Awards 2025

Mumbai, 18th July 2025 — Collins (India) Pharmaceuticals was recognized with the distinguished title of ‘Most Valuable Partner Award’ at the "Influx Connect" Business Excellence Awards 2025, held at the Jio Convention Center in Mumbai on 12th July 2025.
Presented by The Bharat Biz, the event highlighted organizations that have made significant contributions to the growth, values, and foundations of their partners and the broader wellness ecosystem.
Collins India Pharmaceuticals holds a unique and cherished place in the journey of Influx Healthtech. As Influx’s very first client, Collins India placed its trust and belief in the company at a time when support mattered the most. Through years of collaboration, unwavering faith, and goodwill, they have helped shape Influx’s foundation and ongoing success.
The award acknowledges not just business excellence but also the spirit of enduring partnerships built on mutual respect, integrity, and long-term vision.
The award was presented by Mr. Shirish K. Dabhade, former Assistant Commissioner (WHO-GMP Cell), Executive Council Member of IPCA, and former President of AIDCOC — a stalwart in pharmaceutical regulation known for his impactful contributions to the industry.
This recognition is a heartfelt tribute to Collins (India) Pharmaceuticals for being more than a client — a cornerstone in Influx Healthtech’s story and a partner in every sense of the word.